Taro Pharmaceuticals U.S.A.

Taro Pharmaceuticals U.S.A., Inc. was founded in 1988 and is headquartered in Hawthorne, New York. Taro Pharmaceuticals U.S.A., Inc. is a subsidiary of Taro Pharmaceutical Industries Ltd. Taro is a research-based international pharmaceutical company established on the principle that research and development will be the cornerstone of its growth strategy. Delivering high-quality products through scientific innovation, diligence, and precision is the goal of all Taro's research initiatives. Taro develops high-quality, proprietary, and generic drugs for markets in the United States, Canada, Israel, and other countries worldwide. The company sells a wide range of prescription and over-the-counter medications in the U.S., is a leading manufacturer and supplier of dermatology products, and has a growing portfolio of solid dosage form products primarily used in cardiology and neurology.